Amgen | AMGN - Net Income

Stock Price
339.57
Daily Change
-0.61 -0.18%
Monthly
-2.70%
Yearly
17.68%
Q2 Forecast
337.18

Amgen reported $1.33B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Agios Pharmaceuticals USD -108.04M 4.61M Dec/2025
ALKERMES USD 49.34M 33.42M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
BioMarin Pharmaceutical USD -46.57M 15.83M Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Exelixis USD 193.58M 8.73M Sep/2025
Genmab DKK 31M 370M Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Glaxosmithkline GBP 846.06M 1.87B Dec/2025
Incyte USD 299.28M 124.89M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
J&J USD 5.24B 119M Mar/2026
Merck USD 2.96B 2.82B Dec/2025
Moderna USD -200M 625M Sep/2025
Neurocrine Biosciences USD 209.5M 102M Sep/2025
Novartis USD 2.41B 1.52B Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
PTC Therapeutics USD -134.96M 150.86M Dec/2025
Puma Biotechnology USD 20.32M 24.85M Sep/2024
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
Sarepta Therapeutics USD -412.23M 232.28M Dec/2025
Takeda JPY 103.64B 115.44B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
Ultragenyx Pharmaceutical USD -129M 51.41M Dec/2025
Vertex Pharmaceuticals USD 1.19B 108.2M Dec/2025